Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 1;353(6294):45-50.
doi: 10.1126/science.aaf7865. Epub 2016 Jun 2.

Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation

Bryan A Gibson  1 , Yajie Zhang  2 , Hong Jiang  3 , Kristine M Hussey  4 , Jonathan H Shrimp  3 , Hening Lin  3 , Frank Schwede  5 , Yonghao Yu  2 , W Lee Kraus  6
Affiliations

Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation

Bryan A Gibson et al. Science. .

Abstract

Poly[adenosine diphosphate (ADP)-ribose] polymerases (PARPs) are a family of enzymes that modulate diverse biological processes through covalent transfer of ADP-ribose from the oxidized form of nicotinamide adenine dinucleotide (NAD(+)) onto substrate proteins. Here we report a robust NAD(+) analog-sensitive approach for PARPs, which allows PARP-specific ADP-ribosylation of substrates that is suitable for subsequent copper-catalyzed azide-alkyne cycloaddition reactions. Using this approach, we mapped hundreds of sites of ADP-ribosylation for PARPs 1, 2, and 3 across the proteome, as well as thousands of PARP-1-mediated ADP-ribosylation sites across the genome. We found that PARP-1 ADP-ribosylates and inhibits negative elongation factor (NELF), a protein complex that regulates promoter-proximal pausing by RNA polymerase II (Pol II). Depletion or inhibition of PARP-1 or mutation of the ADP-ribosylation sites on NELF-E promotes Pol II pausing, providing a clear functional link between PARP-1, ADP-ribosylation, and NELF. This analog-sensitive approach should be broadly applicable across the PARP family and has the potential to illuminate the ADP-ribosylated proteome and the molecular mechanisms used by individual PARPs to mediate their responses to cellular signals.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Structure-based engineering of an NAD+ analog-sensitive PARP-1 (asPARP-1) mutant
(A) (Left) Schematic illustrating NAD+ analog-sensitivity in PARP proteins. (Right) Residues in PARP-1 selected for mutation to glycine or alanine for discovery of gatekeeper residues. (B) Chemical structures of the 11 NAD+ analogs used for screening for asPARP-1. (C) Western blot for ADP-ribose from automodification reactions containing PARP-1 or PARP-1 mutants (L877A and I895A) and NAD+ or NAD+ analogs. (D) Depiction of the spatial relationship between position 8 of the adenine ring in NAD+ and the gatekeeper residues.
Figure 2
Figure 2. Activity of asPARPs 1, 2, and 3 with a clickable NAD+ analog
(A) Chemical structure of the bi-functional NAD+ analog 8-Bu(3-yne)T-NAD+ with the clickable analog sensitivity-inducing, alkyne-containing R group highlighted in red. (B) Schematic illustrating asPARP activity-dependent, click chemistry-mediated covalent attachment of fluorophores, biotin, or agarose resin to 8-Bu(3-yne)T-ADP-ribosylated proteins. (C) Automodification reactions with wild-type or analog-sensitive PARP-1, PARP-2, and PARP-3 analyzed by Western blotting for ADP-ribose (top) or click chemistry-based in-gel fluorescence (bottom).
Figure 3
Figure 3. Using analog-sensitive PARP-1 mutants to unambiguously identify the ADP-ribosylation targets of DNA-dependent PARPs
(A) In-gel fluorescence of HeLa cell nuclear extract proteins conjugated to azido-TAMRA following reactions with 8-Bu(3-yne)T-NAD+ in the presence of wild-type (wt) or analog-sensitive (as) PARP-1, PARP-2, or PARP-3. (B) Depiction of the strategy for LC-MS/MS detection of PARP-specific ADP-ribosylation sites. (Left) asPARP-dependent labeling of HeLa cell nuclear extract (N.E.) proteins (represented by various shapes) using 8-Bu(3-yne)T-NAD+ (red). (Right) Post-labeling sample processing for LC-MS/MS. The 8-Bu(3-yne)T-ADP-ribosylated proteins are covalently linked to azide-agarose by copper-catalyzed cycloaddition (‘click’ chemistry; represented by pentagons), washed, and digested with trypsin to release peptides for protein identification. The remaining covalently linked peptides are eluted using hydroxyl amine (NH2OH) with a mass shift of 15.0109 Da, which allows for identification of ADP-ribosylation sites. (C) Venn diagram depicting the overlap of the protein targets of PARP-1, PARP-2, and PARP-3. (D) Gene ontology terms enriched for the sets of PARP-1, PARP-2 and PARP-3 targets. (E) Histogram of the two-dimensional relationship between previously identified ADP-ribosylation sites (9) with those identified herein.
Figure 4
Figure 4. P-TEFb-dependent ADP-ribosylation of NELF by PARP-1
(A) Schematic showing the distribution of PARP-1 ADP-ribosylation sites (red), P-TEFb phosphorylation sites, and a PARP target-enriched 7-mer RSRSRDR (green) on proteins in the NELF complex. (B) Western blot analysis of immunoprecipitated FLAG-tagged NELF-E or GFP from 293T cells. (C) Silver stained SDS-PAGE gel (left) and ADP-ribose Western blot (right) of immunopurified NELF complex. Asterisk = automodified PARP-1. (D) Western blot for ADP-ribose of in vitro modification reactions containing GST, GST-tagged wild-type NELF-E, or GST-tagged ADP-ribosylation site point mutant NELF-E, PARP-1, and NAD+ as indicated. (E) NELF-E/TAR RNA electrophoretic mobility shift assay with or without PARP-1-mediated ADP-ribosylation. GST or GST-NELF-E was titrated between 0.1 to 1.0 μM and NAD+ was added at 25 μM (+) or 100 μM (++) during the ADP-ribosylation reaction. (F) Histogram of the relationship between ADP-ribosylation sites identified herein and the nearest incidence of known phosphorylation modifications on PARP target proteins. (G) Western blot analysis of immunoprecipitated FLAG-tagged NELF-E from 293T cells treated with vehicle, the PARP inhibitor PJ34, or the P-TEFb/CDK9 inhibitor flavopiridol.
Figure 5
Figure 5. Click-ChIP-seq, an asPARP-1-based method for identifying the genome-wide distribution of ADP-ribosylation events catalyzed by a specific PARP protein
(A) Schematic representation of Click-ChIP-seq. Nuclei are isolated from Parp−/− MEFs expressing asPARP-1, labeled with 8-Bu(3-yne)T-NAD+, subjected to crosslinking with formaldehyde, and then processed for chromatin immunoprecipitation. The enriched DNA is subjected to deep sequencing. (B) Genome browser view of a multi-gene locus of the mouse genome showing PARP-1-catalyzed ADP-ribosylation (from Click-ChIP-seq) with other genomic features. (C) Heat map showing pairwise clustered correlations between genomic features and PARP-1-mediated ADP-ribosylation from click-ChIP-seq. (D) Heat map representations showing PARP-1-catalyzed ADP-ribosylation (from Click-ChIP-seq) in comparison to PARP-1 (from ChIP-seq) and transcription (from GRO-seq) at the promoters of all RefSeq genes.
Figure 6
Figure 6. Functional links between PARP-1-catalyzed ADP-ribosylation, NELF binding, and RNA polymerase II pausing genome-wide
(A) Metagenes of GRO-seq read density at the promoters of all expressed RefSeq genes from MCF-7 cells subjected to shRNA-mediated knockdown with either control/luciferase or PARP-1 shRNAs (top) or treatment with the PARP inhibitor (PARPi) PJ34 (bottom). (B) RNA polymerase II pausing indices at the promoters of all transcribed RefSeq genes from MCF-7 cells subjected to shRNA-mediated knockdown with either control/luciferase or PARP-1 shRNAs or treatment with PJ34. (C) Boxplots of promoter proximal Pol II “pausing efficacy” determined by Pol II and NELF ChIP-seq in MCF-7 cells under the different experimental conditions indicated for the top quartile of expressed RefSeq genes. Bars marked with different letters are significantly different (p < 2.16 × 10−16; t-test).
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gibson BA, Kraus WL. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol. 2012;13:411. - PubMed
    1. Vyas S, et al. Family-wide analysis of poly(ADP-ribose) polymerase activity. Nat Commun. 2014;5:4426. - PMC - PubMed
    1. Hottiger MO. Nuclear ADP-ribosylation and its role in chromatin plasticity, cell differentiation, and epigenetics. Annu Rev Biochem. 2015;84:227. - PubMed
    1. Daniels CM, Ong SE, Leung AK. The Promise of Proteomics for the Study of ADP-Ribosylation. Mol Cell. 2015;58:911. - PMC - PubMed
    1. Carter-O’Connell I, Jin H, Morgan RK, David LL, Cohen MS. Engineering the substrate specificity of ADP-ribosyltransferases for identifying direct protein targets. J Am Chem Soc. 2014;136:5201. - PMC - PubMed

Publication types

MeSH terms